Utilization and likelihood of radiologic diagnostic imaging in patients with implantable cardiac defibrillators

Journal of Magnetic Resonance Imaging

Volumn 43, Issue 1, 2016, Pages 115-127

  Nazarian, Saman ^a   Reynolds, Matthew R ^b   Ryan, Michael P ^c   Wolff, Steven D ^d   Mollenkopf, Sarah A ^e   Turakhia, Mintu P ^f  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b HARVARD CLINICAL RESEARCH INSTITUTE   (United States)

^c CTI Clinical Trial and Consulting Services   (United States)

^d Carnegie Hill Radiology   (United States)

^e MEDTRONIC   (United States)

^f STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

defibrillation; healthcare utilization; heart assist device; implantable cardioverter defibrillators; magnetic resonance imaging

Indexed keywords

ADULT; AGED; ARTHRALGIA; ARTICLE; BACKACHE; CEREBROVASCULAR ACCIDENT; COMORBIDITY; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; ECHOGRAPHY; FEMALE; FLUOROSCOPY; HUMAN; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; MAGNETIC RESONANCE ANGIOGRAPHY; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RADIOGRAPHY; TRANSIENT ISCHEMIC ATTACK; UNITED STATES; ADOLESCENT; CHILD; CLINICAL PRACTICE; COHORT ANALYSIS; CONTRAINDICATIONS; EPIDEMIOLOGY; INFANT; LONGITUDINAL STUDY; MIDDLE AGED; NEWBORN; PRESCHOOL CHILD; UTILIZATION; UTILIZATION REVIEW; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; DEFIBRILLATORS, IMPLANTABLE; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; LONGITUDINAL STUDIES; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; PRACTICE PATTERNS, PHYSICIANS'; UNITED STATES; UTILIZATION REVIEW; YOUNG ADULT;

EID: 84955722369     PISSN: 10531807     EISSN: 15222586     Source Type: Journal    
DOI: 10.1002/jmri.24971     Document Type: Article

References (30)

1. Medpac: Medicare Payment Advisory Commission. A Data Book. Health Care Spending and the Medicare Program. June, 2014.
2. United States Government Accountability Office. Medicare Part B Imaging Services. Rapid Spending Growth and Shift to Physician Offices Indicate Need for CMS to Consider Additional Management Practices. GAO-08-452. June, 2008.
3. Smith-Bindman R, Miglioretti DL, Larson EB,. Rising use of diagnostic medical imaging in a large integrated health system. Health Aff (Millwood) 2008; 27: 1491-1502.
4. Kalin R, Stanton MS,. Current clinical issues for MRI scanning of pacemaker and defibrillator patients. Pacing Clin Electrophysiol 2005; 28: 326-328.
5. American College of Radiology. ACR Appropriateness Criteria®. http://www.acr.org/Quality-Safety/Appropriateness-Criteria.
6. Jauch EC, Saver JL, Adams HP Jr, et al., Guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 2013; 44: 870-947.
7. Schellinger PD, Bryan RN, Caplan LR, et al., Evidence-based guideline: the role of diffusion and perfusion MRI for the diagnosis of acute ischemic stroke: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology 2010; 75: 177-185.
8. Wintermark M, Sanelli PC, Albers GW, et al., Imaging recommendations for acute stroke and transient ischemic attack patients: a joint statement by the American Society of Neuroradiology, the American College of Radiology, and the Society of NeuroInterventional Surgery. AJNR Am J Neuroradiol 2013; 34: E117-127.
9. Roguin A, Schwitter J, Vahlhaus C, et al., Magnetic resonance imaging in individuals with cardiovascular implantable electronic devices. Europace 2008; 10: 336-346.
10. Marcu CB, Beek AM, van Rossum AC,. Clinical applications of cardiovascular magnetic resonance imaging. CMAJ 2006; 175: 911-917.
11. Gotte MJ, Russel IK, de Roest GJ, et al., Magnetic resonance imaging, pacemakers and implantable cardioverter-defibrillators: current situation and clinical perspective. Neth Heart J 2010; 18: 31-37.
12. Nazarian S, Halperin HR,. How to perform magnetic resonance imaging on patients with implantable cardiac arrhythmia devices. Heart Rhythm 2009; 6: 138-143.
13. Levine GN, Gomes AS, Arai AE, et al., Safety of magnetic resonance imaging in patients with cardiovascular devices: an American Heart Association scientific statement from the Committee on Diagnostic and Interventional Cardiac Catheterization, Council on Clinical Cardiology, and the Council on Cardiovascular Radiology and Intervention: endorsed by the American College of Cardiology Foundation, the North American Society for Cardiac Imaging, and the Society for Cardiovascular Magnetic Resonance. Circulation 2007; 116: 2878-2891.
14. Nazarian S, Beinart R, Halperin HR,. Magnetic resonance imaging and implantable devices. Circ Arrhythm Electrophysiol 2013; 6: 419-428.
15. Greenspon AJ, Patel JD, Lau E, et al., Trends in permanent pacemaker implantation in the United States from 1993 to 2009: increasing complexity of patients and procedures. J Am Coll Cardiol 2012; 60: 1540-1545.
16. Kremers MS, Hammill SC, Berul CI, et al., The National ICD Registry Report: version 2.1 including leads and pediatrics for years 2010 and 2011. Heart Rhythm 2013; 10: e59-65.
17. U.S. Food and Drug Administration. A Primer on Medical Device Interactions with Magnetic Resonance Imaging Systems. http://www.fda.gov/MedicalDevices/DeviceRegulationandGuidance/GuidanceDocuments/ucm107721.htm.
18. Verma A, Ha AC, Dennie C, et al., Canadian heart rhythm society and canadian association of radiologists consensus statement on magnetic resonance imaging with cardiac implantable electronic devices. Can J Cardiol 2014; 30: 1131-1141.
19. Nazarian S, Hansford R, Roguin A, et al., A prospective evaluation of a protocol for magnetic resonance imaging of patients with implanted cardiac devices. Ann Intern Med 2011; 155: 415-424.
20. Cohen JD, Costa HS, Russo RJ,. Determining the risks of magnetic resonance imaging at 1.5 Tesla for patients with pacemakers and implantable cardioverter defibrillators. Am J Cardiol 2012; 110: 1631-1636.
21. Breslin TM, Banerjee M, Gust C, Birkmeyer NJ,. Trends in advanced imaging use for women undergoing breast cancer surgery. Cancer 2013; 119: 1251-1256.
22. Lee DW, Foster DA,. The association between hospital outcomes and diagnostic imaging: early findings. J Am Coll Radiol 2009; 6: 780-785.
23. Mayo Clinic. Gmatch macro developed by Erik Bergstralh and Jon Kosanke. 2003 http://www.mayo.edu/research/departments-divisions/department-health-sciences-research/division-biomedical-statistics-informatics/software/locally-written-sas-macros.
24. Parsons LS. Reducing Bias in a Propensity Score Matched-Pair Sample Using Greedy Matching Techniques. Paper presented at the Proceedings of the 26th Annual SAS Users Group International Conference. 2001. http://www2.sas.com/proceedings/sugi26/p214-26.pdf.
25. Lang K, Huang H, Lee DW, Federico V, Menzin J,. National trends in advanced outpatient diagnostic imaging utilization: an analysis of the medical expenditure panel survey, 2000-2009. BMC Med Imaging 2013; 13: 40.
26. Levin DC, Rao VM, Parker L,. Trends in the utilization of outpatient advanced imaging after the deficit reduction act. J Am Coll Radiol 2012; 9: 27-32.
27. Marinskis G, Bongiorni MG, Dagres N, Dobreanu D, Lewalter T, Blomstrom-Lundqvist C,. Performing magnetic resonance imaging in patients with implantable pacemakers and defibrillators: results of a European Heart Rhythm Association survey. Europace 2012; 14: 1807-1809.
28. Russo RJ,. Determining the Risks of Magnetic Resonance Imaging at 1.5 Tesla for Patients with Non-MRI Conditional Pacemakers and Implantable Cardioverter Defibrillators: Final Results of The MagnaSafe Registry. Presentation at American Heart Association Scientific Sessions 2014: November 18, 2014 Chicago, IL.
29. van der Graaf AW, Bhagirath P, Gotte MJ,. MRI and cardiac implantable electronic devices; current status and required safety conditions. Neth Heart J 2014; 22: 269-276.
30. Brignole M, Auricchio A, Baron-Esquivias G, et al., 2013 ESC guidelines on cardiac pacing and cardiac resynchronization therapy: the task force on cardiac pacing and resynchronization therapy of the European Society of Cardiology (ESC). Developed in collaboration with the European Heart Rhythm Association (EHRA). Europace 2013; 15: 1070-1118.